Abstract
Stevens–Johnson syndrome (SSD) and toxic epidermal necrolysis (TEN) are life–threatening conditions accompanied by skin lesions, as well as in some cases mucous membranes, manifested by necrosis and detachment of the epidermis. These conditions are considered urgent and require emergency hospitalization. Most often, these conditions develop when taking drugs, but in some cases it is not possible to find out the cause of the disease. In described case, we discovered this condition in a patient, who received immunotherapy with pembrolizumab, a monoclonal antibody to the PD-1 receptor, which generally used in the treatment of cancer patients.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
